Profil
Lionel M.
Nelson has been Medical Director of Apneon, Inc. since 2003.
He is a Clinical Associate Professor at the Stanford University School of Medicine.
Dr. Nelson served in the US Army Special Operations as a Colonel.
He received an undergraduate degree in Physics from the City University of New York and a Medical degree from the Yale University School of Medicine.
Dr. Nelson completed his post-graduate Surgical and Otolaryngologic training at the University of California, San Diego, and Stanford.
Postes actifs de Lionel M. Nelson
| Sociétés | Poste | Début |
|---|---|---|
Apneon, Inc.
 Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | Fondateur | 16/02/2010 |
Formation de Lionel M. Nelson
| Yale University | Doctorate Degree |
| City University of New York | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Apneon, Inc.
Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | Health Technology |
